ArticleScience (New York, N.Y.)2025

Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity.

David Kung-Chun Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.